Matches in Wikidata for { <http://www.wikidata.org/entity/Q83807044> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q83807044 description "clinical trial" @default.
- Q83807044 description "ensayu clínicu" @default.
- Q83807044 description "klinisch onderzoek" @default.
- Q83807044 description "клінічне випробування" @default.
- Q83807044 name "A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)" @default.
- Q83807044 name "A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)" @default.
- Q83807044 type Item @default.
- Q83807044 label "A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)" @default.
- Q83807044 label "A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)" @default.
- Q83807044 prefLabel "A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)" @default.
- Q83807044 prefLabel "A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)" @default.
- Q83807044 P1132 Q83807044-AD41C464-9482-4B3F-95CA-05F8F2106E85 @default.
- Q83807044 P1476 Q83807044-2376C5C7-38ED-49F2-A32C-3698DCFA6B84 @default.
- Q83807044 P2899 Q83807044-D8B1F3C0-96DC-41BE-AA2C-5706A9BF11E1 @default.
- Q83807044 P3098 Q83807044-F0F14C24-29B2-44B5-954F-230F9B0A8D98 @default.
- Q83807044 P31 Q83807044-50A0DB43-4337-4B4E-8906-A2A862150581 @default.
- Q83807044 P4135 Q83807044-46D65FD0-E920-409B-B58E-CE1276BF8B61 @default.
- Q83807044 P4844 Q83807044-3D2727F2-8A8B-47D9-9AB9-3D07E1807B9A @default.
- Q83807044 P4844 Q83807044-D86412E4-5BE5-4B24-AEF2-E71E84BBA85D @default.
- Q83807044 P580 Q83807044-9C5DFC6E-9E11-4E72-B06C-303B98D28839 @default.
- Q83807044 P582 Q83807044-5112D50E-9252-4AFC-AABA-60D231A57048 @default.
- Q83807044 P6099 Q83807044-1E7B0513-1B8D-43E0-8F5D-94370EA913C4 @default.
- Q83807044 P8363 Q83807044-47F1148D-4AE1-4693-BC7A-039ECB2740DA @default.
- Q83807044 P1132 "+738" @default.
- Q83807044 P1476 "A Randomized, Double-blind, Controlled, Multicenter Phase III Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer" @default.
- Q83807044 P2899 "+18" @default.
- Q83807044 P3098 "NCT04234607" @default.
- Q83807044 P31 Q30612 @default.
- Q83807044 P4135 "+75" @default.
- Q83807044 P4844 Q27260984 @default.
- Q83807044 P4844 Q415588 @default.
- Q83807044 P580 "2020-01-01T00:00:00Z" @default.
- Q83807044 P582 "2022-12-01T00:00:00Z" @default.
- Q83807044 P6099 Q42824827 @default.
- Q83807044 P8363 Q78089383 @default.